Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease

Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease

Bibliographic Details
Main Authors:	Yates, Sharon C, Zafar, Amen, Hubbard, Paul, Nagy, Sheila, Durant, Sarah, Bicknell, Roy, Wilcock, Gordon, Christie, Sharon, Esiri, Margaret M, Smith, A David, Nagy, Zsuzsanna
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776211/

Similar Items

The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer’s Disease in a Population of European Descent
by: Yates, Sharon C., et al.
Published: (2015)

mTOR-dependent signalling in Alzheimer's disease
by: Pei, Jin-Jing, et al.
Published: (2008)

Activation of mTOR: a culprit of Alzheimer’s disease?
by: Cai, Zhiyou, et al.
Published: (2015)

mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
by: Larisa Ryskalin, et al.
Published: (2018-07-01)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
by: Gao, Wei, et al.
Published: (2012)

mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01)

Targeting glutaminase and mTOR
by: Tanaka, Kazuhiro, et al.
Published: (2015)

mTOR, autophagy, and reprogramming
by: Tang, Bor Luen
Published: (2014)

mTOR and lysosome regulation
by: Puertollano, Rosa
Published: (2014)

Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
by: Wang Xu, et al.
Published: (2016-01-01)

mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel
by: Huang, Tai-Qin, et al.
Published: (2015)

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors
by: Hassan, Burhan, et al.
Published: (2014)

The Paradox of Akt-mTOR Interactions
by: Vadlakonda, Lakshmipathi, et al.
Published: (2013)

Where is mTOR and what is it doing there?
by: Betz, Charles, et al.
Published: (2013)

Biological Aspects of mTOR in Leukemia
by: Simone Mirabilii, et al.
Published: (2018-08-01)

mTOR inhibitors in cancer therapy
by: Xie, Jianling, et al.
Published: (2016)

Inhibitors of mTOR in aging and cancer
by: Zhavoronkov, Alexander
Published: (2015)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Gipson, Tanjala T., et al.
Published: (2012)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
by: Gamper, Christopher J., et al.
Published: (2012)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
by: Raychaudhuri, Smriti K, et al.
Published: (2014)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
by: Cao, Guo-dong, et al.
Published: (2016)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
by: Rodrik-Outmezguine, Vanessa S., et al.
Published: (2016)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
by: Renna, Maurizio
Published: (2016)

Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways
by: Gan, Boyi, et al.
Published: (2006)

The mTOR Signalling Pathway in Human Cancer
by: Pópulo, Helena, et al.
Published: (2012)

Targeting the mTOR pathway in Chromophobe Kidney Cancer
by: Shuch, Brian, et al.
Published: (2012)

Akt and mTOR in B Cell Activation and Differentiation
by: Limon, Jose J., et al.
Published: (2012)

Dissecting the role of mTOR complexes in cellular senescence
by: Serrano, Manuel
Published: (2012)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
by: Yim, Kein-Leong
Published: (2012)

mTOR Inhibition: From Aging to Autism and Beyond
by: Kaeberlein, Matt
Published: (2013)

Exploiting the mTOR paradox for disease prevention
by: Iglesias-Bartolome, Ramiro, et al.
Published: (2012)

Optimising the use of mTOR inhibitors in renal transplantation
by: Russ, Graeme R
Published: (2013)

mTOR, AMBRA1, and autophagy: An intricate relationship
by: Nazio, Francesca, et al.
Published: (2013)

mTOR regulates phagosome and entotic vacuole fission
by: Krajcovic, Matej, et al.
Published: (2013)

mTOR inhibition in management of advanced breast cancer
by: Nag, Shona
Published: (2012)

mTOR Inhibitors in Tuberous Sclerosis Complex
by: Curatolo, Paolo, et al.
Published: (2012)

Reversing autism by targeting downstream mTOR signaling
by: Wang, Hansen, et al.
Published: (2013)

Clinical development of mTOR inhibitors in breast cancer
by: Vicier, Cecile, et al.
Published: (2014)

Role of mTOR inhibitor in cholangiocarcinoma cell progression
by: MOOLTHIYA, PENPAK, et al.
Published: (2014)

SYK Regulates mTOR Signaling in AML
by: Carnevale, Julia, et al.
Published: (2013)